公开(公告)号：US20180221635A1

公开(公告)日：2018-08-09

申请号：US15748184

申请日：2016-07-29

Applicant: OSONG MEDICAL INNOVATION FOUNDATION

Inventor： Jin-Hee MOON ,  In-Ho SONG ,  Jin-Won KIM ,  Seung-A LEE ,  Ha-Chul JUNG ,  Jin-Won AHN ,  Sang-Hun LEE ,  A-Hee KIM

IPC: A61M37/00 ,  A61M31/00 ,  A61N1/05 ,  B81B1/00 ,  B81C1/00

CPC classification number: A61M37/00 ,  A61M31/002 ,  A61M2037/0007 ,  A61M2037/0023 ,  A61M2037/003 ,  A61M2205/04 ,  A61M2205/054 ,  A61M2207/00 ,  A61N1/05 ,  B81B1/00 ,  B81B1/008 ,  B81B3/00 ,  B81B7/02 ,  B81B2201/055 ,  B81B2203/0338 ,  B81C1/00 ,  B81C1/00111 ,  B81C3/00

Abstract: In an implantable hybrid lead and a method of manufacturing the implantable hybrid lead, the implantable hybrid lead includes a conduit, a line electrode and a plurality of electrode terminals. The conduit has a fine channel through which a medicine is injected. The line electrode is inserted to and is combined with an outside of the conduit, and applies electrical simulation to a selected portion of a living body. A plurality of electrode terminals is disposed at an end of the conduit by a predetermined distance.